Update on the Sentinel Node Procedure in Vulvar Cancer
In conclusion, the SN procedure is an established procedure in early-stage VSCC, although optimization of the technique, pathologic workup, indications, and treatment in the setting of metastatic disease are the subject of ongoing research.PMID:38503055 | DOI:10.6004/jnccn.2024.7002 (Source: Journal of the National Comprehensive Cancer Network : JNCCN)
Source: Journal of the National Comprehensive Cancer Network : JNCCN - March 19, 2024 Category: Cancer & Oncology Authors: Willemijn L van der Kolk Joost Bart Ate J G van der Zee Maaike H M Oonk Source Type: research
Evaluation of Vulvar Disorders by Vulvoscopy Index and N-S-P Scheme Using Three Rings Vulvoscopy (TRIV)
ConclusionThe Vulvoscopy Index is a significant predictor for vulvar disorders. N-S-P scheme helps in the objective and systematic documentation of TRIV findings, which allows monitoring of the vulvar changes. TRIV can be used for preventing early stages of vulvar dermatosis which is a risk factor for vulvar malignancy. (Source: The Journal of Obstetrics and Gynecology of India)
Source: The Journal of Obstetrics and Gynecology of India - March 13, 2024 Category: OBGYN Source Type: research
Sentinel node biopsy in gynaecological cancers: state of art and future perspectives
ConclusionSentinel node biopsy has been widely validated in well-selected patients with early-stage vulvar, cervical and endometrial cancers. It is essential to standardise the acquisition protocol, including SPECT/CT imaging, for an improved surgical planning and a personalised approach. Recent technological advances, such as hybrid tracers and intraoperative tools, may efficiently guide gynaecological cancer surgery. (Source: Clinical and Translational Imaging)
Source: Clinical and Translational Imaging - March 4, 2024 Category: Radiology Source Type: research
Differentiated vulvar intraepithelial neoplasia long ‐term follow up and prognostic factors: An analysis of a large historical cohort
ConclusionsPatients with dVIN have a high risk of developing both primary and recurring VSCC. Early recognition, long-term follow up, and compliant ultrapotent topical corticosteroid treatment are recommended. (Source: Acta Obstetricia et Gynecologica Scandinavica)
Source: Acta Obstetricia et Gynecologica Scandinavica - February 22, 2024 Category: OBGYN Authors: Niccol ò Gallio,
Mario Preti,
Ronald W. Jones,
Fulvio Borella,
Linn Woelber,
Luca Bertero,
Sara Urru,
Leonardo Micheletti,
Federica Zamagni,
Federica Bevilacqua,
Pierluigi Tondo,
Benedetta Pollano,
Paola Cassoni,
Chiara Benedetto Tags: ORIGINAL RESEARCH ARTICLE Source Type: research
